Patients bearing PIK3CA mutations showed a significant poor overall survival (p = 0.0289) compared with people bearing wild-type PIK3CA suggesting the important role of this gene in aggressive thyroid cancer. This evidence concerns the gene PIK3CA and thyroid gland carcinoma.